GPAT
NASDAQ · N/A
Gp-Act Iii Acquisition-A
$11.08
+0.09 (+0.82%)
Open$11.07
Previous Close$10.99
Day High$11.09
Day Low$11.07
52W High$12.00
52W Low$10.57
Volume—
Avg Volume20.6K
Market Cap179.07M
P/E Ratio21.21
EPS$0.24
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 208.86M | 186.14M | 170.16M |
| Net Income | 16.91M | 14.74M | 15.51M |
| Profit Margin | 8.1% | 7.9% | 9.1% |
| EBITDA | 35.39M | 34.71M | 28.86M |
| Free Cash Flow | 27.19M | 19.88M | 18.98M |
| Rev Growth | +18.7% | +1.7% | +5.6% |
| Debt/Equity | 1.10 | 1.12 | 1.24 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $2.96 | -7.50% | — | 2.01B |
| PICS | Pics Nv | $8.19 | -1.56% | 4.4 | 1.13B |
| DMII | Drugs Made In America Acquis | $10.18 | +0.15% | 49.7 | 646.56M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.69 | -0.19% | 42.2 | 335.42M |
| CEPF | Cantor Equity Partners-Cl A | $10.30 | +0.15% | 41.3 | 587.79M |